This was a virtual discussion on how IP protections have been key to addressing the current pandemic as well as how the U.S. and India can work together towards fact-based solutions for IP challenges in the biopharmaceutical space. Dr. Kapoor shared his views on Indian IPR in the Age of COVID-19 on December 3, 2020 at a virtual session organised by GIPC. The other panellists are as follows:

Robert Grant, John Cabeca, Kate Beale, Narendra Sabharwal and Malathi Lakshmikumaran.

The detailed agenda can be looked here.

0 Comments

Leave a reply

Your email address will not be published. Required fields are marked *

*

© 2021 AMIT Kapoor

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending

Log in with your credentials

Forgot your details?